⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tetrathiomolybdate

Every month we try and update this database with for tetrathiomolybdate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast CancerNCT00195091
Breast Cancer
Tetrathiomolybd...
18 Years - Memorial Sloan Kettering Cancer Center
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung CancerNCT01837329
Non-Small Cell ...
Tetrathiomolybd...
18 Years - University of Rochester
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung CancerNCT01837329
Non-Small Cell ...
Tetrathiomolybd...
18 Years - University of Rochester
A Study of Tetrathiomolybdate (TM) Plus CapecitabineNCT06134375
Triple Negative...
Residual Diseas...
Tetrathiomolybd...
Capecitabine
Pembrolizumab
18 Years - 70 YearsDartmouth-Hitchcock Medical Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: